Literature DB >> 19281043

[Characteristics of human lipoaspirate-isolated mesenchymal stromal cells cultivated under a lower oxygen tension].

L B Buravkova, O S Grinakovskaia, E P Andreeva, A P Zhambalova, M P Kozionova.   

Abstract

In the present study we investigated the effect of low oxygen concentration in the cultivation medium on proliferation, viability and immunophenotype of human mesenchymal stromal cells isolated from lipoaspirate (lMSC). It was shown that proliferation activity of the cells under hypoxic conditions was, on average, 2.9 times higher compared to that under commonly accepted normoxic conditions. Redused oxygen level in the culture medium did not cause any change in IMSC viability and immunophenotype. Thus, permanent culture of lMSC in the medium with a lower oxygen tension can prove an efficient approach to obtain a higher mass of cells which maintain their characteristics in a shorter period of time, which can be of demand for regenerative medicine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19281043

Source DB:  PubMed          Journal:  Tsitologiia        ISSN: 0041-3771


  15 in total

Review 1.  Factors governing the immunosuppressive effects of multipotent mesenchymal stromal cells in vitro.

Authors:  Aleksandra Gornostaeva; Elena Andreeva; Ludmila Buravkova
Journal:  Cytotechnology       Date:  2015-08-13       Impact factor: 2.058

2.  WNT-associated gene expression in human mesenchymal stromal cells under hypoxic stress.

Authors:  O O Udartseva; E R Andreeva; L B Buravkova
Journal:  Dokl Biochem Biophys       Date:  2016-01-05       Impact factor: 0.788

3.  The Differential Expression of Adhesion Molecule and Extracellular Matrix Genes in Mesenchymal Stromal Cells after Interaction with Cord Blood Hematopoietic Progenitors.

Authors:  L B Buravkova; E R Andreeva; M V Lobanova; E V Cotnezova; A I Grigoriev
Journal:  Dokl Biochem Biophys       Date:  2018-05-19       Impact factor: 0.788

4.  Mesenchymal stem cell response to growth factor treatment and low oxygen tension in 3-dimensional construct environment.

Authors:  Thomas John Sakrison Durant; Nathaniel Dyment; Mary Beth R McCarthy; Mark P Cote; Robert A Arciero; Augustus D Mazzocca; David Rowe
Journal:  Muscles Ligaments Tendons J       Date:  2014-05-08

5.  Pre-culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potentials.

Authors:  M G Valorani; E Montelatici; A Germani; A Biddle; D D'Alessandro; R Strollo; M P Patrizi; L Lazzari; E Nye; W R Otto; P Pozzilli; M R Alison
Journal:  Cell Prolif       Date:  2012-06       Impact factor: 6.831

6.  Expression of senescence-associated genes in multipotent mesenchymal stromal cells during long-term cultivation at various hypoxic levels.

Authors:  M V Lobanova; A Y Ratushnyy; L B Buravkova
Journal:  Dokl Biochem Biophys       Date:  2016-11-06       Impact factor: 0.788

7.  Benefits of hypoxic culture on bone marrow multipotent stromal cells.

Authors:  Chih-Chien Tsai; Tu-Lai Yew; Der-Chi Yang; Wei-Hua Huang; Shih-Chieh Hung
Journal:  Am J Blood Res       Date:  2012-10-20

8.  Interaction of allogeneic adipose tissue-derived stromal cells and unstimulated immune cells in vitro: the impact of cell-to-cell contact and hypoxia in the local milieu.

Authors:  Aleksandra N Gornostaeva; Elena R Andreeva; Polina I Bobyleva; Ludmila B Buravkova
Journal:  Cytotechnology       Date:  2017-10-03       Impact factor: 2.058

9.  Human adipose-tissue derived stromal cells in combination with hypoxia effectively support ex vivo expansion of cord blood haematopoietic progenitors.

Authors:  Elena R Andreeva; Irina V Andrianova; Elena V Sotnezova; Sergey V Buravkov; Polina I Bobyleva; Yury A Romanov; Ludmila B Buravkova
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

Review 10.  Autologous Stem Cell Therapy: How Aging and Chronic Diseases Affect Stem and Progenitor Cells.

Authors:  Anastasia Yu Efimenko; Tatiana N Kochegura; Zhanna A Akopyan; Yelena V Parfyonova
Journal:  Biores Open Access       Date:  2015-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.